Pipeline Therapeutics, Inc. Report issue

For profit Phase 1 Phase 2
Founded: San Diego CA United States (2017)

Organization Overview

First Clinical Trial
2020
NCT04462198
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Chief Medical Officer, Pipeline Therapeutics, Inc | Chief Medical Officer, Pipeline Therapeutics, Inc. | Pipeline Therapeutics, Inc.